Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › COVID-19 vaccine

COVID-19 vaccine

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of COVID-19 vaccine

4 trials tracked of COVID-19 vaccine: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 37 citations.

4Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Other / NA 2
  1. Phase 3 A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age Completed · 37 cited
  2. Phase 3 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. Completed
  3. N/A COVID-19 Vaccine Response in Sickle Cell Disease Completed
  4. N/A The Impact of Vaccination on Severity of Illness in COVID-19 Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis of real-world studies associates COVID-19 vaccination with improved survival in cancer patients on ICIs
Oncology Meta-analysis
Meta-analysis of real-world studies associates COVID-19 vaccination with improved survival in cancer patients on ICIs Cancer Patients Live Longer After COVID Shots
This meta-analysis of real-world studies evaluated 4,929 cancer patients receiving immune checkpoint inhibitors to assess COVID-19 vaccinati…
It started with a question doctors couldn’t answer: *Should patients on powerful cancer drugs get the COVID vaccine?* Some worried the immun…
Frontiers Apr 23, 2026
ACIP issues interim recommendation for Janssen COVID-19 vaccine in the United States
Allergy & Immunology
ACIP issues interim recommendation for Janssen COVID-19 vaccine in the United States What does the new recommendation for the Johnson & Johnson COVID vaccine mean?
The Advisory Committee on Immunization Practices (ACIP) has issued an interim recommendation for the use of the Janssen COVID-19 vaccine.
A U.S. health committee gave an interim green light for the Johnson & Johnson COVID vaccine as a prevention option after reviewing available…
CDC Apr 4, 2026